Table of Contents
ISRN Nephrology
Volume 2013 (2013), Article ID 191786, 6 pages
http://dx.doi.org/10.5402/2013/191786
Clinical Study

Lack of Influence of Serum Magnesium Levels on Overall Mortality and Cardiovascular Outcomes in Patients with Advanced Chronic Kidney Disease

Nephrology Service, Hospital Severo Ochoa, Avenida Orellana s/n, Leganés 28911, Madrid, Spain

Received 9 May 2013; Accepted 6 June 2013

Academic Editors: C. Escobar, C. Musso, D. G. Struijk, and Y. Takei

Copyright © 2013 Olimpia Ortega et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. G. Massry and M. S. Seelig, “Hypomagnesemia and hypermagnesemia,” Clinical Nephrology, vol. 7, no. 4, pp. 147–153, 1977. View at Google Scholar · View at Scopus
  2. B. M. Altura and B. T. Altura, “New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system. I. Clinical aspects,” Magnesium, vol. 4, no. 5-6, pp. 226–244, 1985. View at Google Scholar · View at Scopus
  3. M. Shechter, C. N. B. Merz, M. Paul-Labrador et al., “Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease,” American Journal of Cardiology, vol. 84, no. 2, pp. 152–156, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Mazur, J. A. M. Maier, E. Rock, E. Gueux, W. Nowacki, and Y. Rayssiguier, “Magnesium and the inflammatory response: potential physiopathological implications,” Archives of Biochemistry and Biophysics, vol. 458, no. 1, pp. 48–56, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Zheng, R. N. Upton, G. L. Ludbrook, and A. Martinez, “Acute cardiovascular effects of magnesium and their relationship to systemic and myocardial magnesium concentrations after short infusion in awake sheep,” Journal of Pharmacology and Experimental Therapeutics, vol. 297, no. 3, pp. 1176–1183, 2001. View at Google Scholar · View at Scopus
  6. A. Zhang, T. P. O. Cheng, and B. M. Altura, “Magnesium regulates intracellular free ionized calcium concentration and cell geometry in vascular smooth muscle cells,” Biochimica et Biophysica Acta, vol. 1134, no. 1, pp. 25–29, 1992. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Kircelli, M. E. Peter, E. Sevinc et al., “Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner,” Nephrology Dialysis Transplantation, vol. 27, no. 2, pp. 514–521, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Salem, H. Bruck, F. H. Bahlmann et al., “Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification,” American Journal of Nephrology, vol. 35, no. 1, pp. 31–39, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Liao, A. R. Folsom, and F. L. Brancati, “Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study,” American Heart Journal, vol. 136, no. 3, pp. 480–490, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Ma, A. R. Folsom, S. L. Melnick et al., “Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the aric study,” Journal of Clinical Epidemiology, vol. 48, no. 7, pp. 927–940, 1995. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Cunningham, M. Rodríguez, P. Messa et al., “Magnesium in chronic kidney disease stage 3 and 4 and in dialysis patients,” Clinical Kidney Journal, vol. 5, supplement 1, pp. i39–i51, 2012. View at Publisher · View at Google Scholar
  12. A. C. Truttmann, R. Faraone, R. O. von Vigier, J. M. Nuoffer, R. Pfister, and M. G. Bianchetti, “Maintenance hemodialysis and circulating ionized magnesium,” Nephron, vol. 92, no. 3, pp. 616–621, 2002. View at Google Scholar · View at Scopus
  13. J. Kelber, E. Slatopolsky, and J. A. Delmez, “Acute effects of different concentrations of dialysate magnesium during high-efficiency dialysis,” American Journal of Kidney Diseases, vol. 24, no. 3, pp. 453–460, 1994. View at Google Scholar · View at Scopus
  14. A. Scholze, V. Jankowski, L. Henning et al., “Phenylacetic acid and arterial vascular properties in patients with chronic kidney disease stage 5 on hemodialysis therapy,” Nephron Clinical Practice, vol. 107, no. 1, pp. c1–c6, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. W. G. Goodman, J. Goldin, B. D. Kuizon et al., “Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis,” The New England Journal of Medicine, vol. 342, no. 20, pp. 1478–1483, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Blacher, A. P. Guerin, B. Pannier, S. J. Marchais, and G. M. London, “Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease,” Hypertension, vol. 38, no. 4, pp. 938–942, 2001. View at Google Scholar · View at Scopus
  17. I. Tzanakis, K. Virvidakis, A. Tsomi et al., “Intra- and extracellular magnesium levels and atheromatosis in haemodialysis patients,” Magnesium Research, vol. 17, no. 2, pp. 102–108, 2004. View at Google Scholar · View at Scopus
  18. F. Turgut, M. Kanbay, M. R. Metin, E. Uz, A. Akcay, and A. Covic, “Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis,” International Urology and Nephrology, vol. 40, no. 4, pp. 1075–1082, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Ishimura, S. Okuno, T. Yamakawa, M. Inaba, and Y. Nishizawa, “Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients,” Magnesium Research, vol. 20, no. 4, pp. 237–244, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. I. Tzanakis, A. Pras, D. Kounali et al., “Mitral annular calcifications in haemodialysis patients: a possible protective role of magnesium,” Nephrology Dialysis Transplantation, vol. 12, no. 9, pp. 2036–2037, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. B. M. Altura and B. T. Altura, “Magnesium and cardiovascular biology: an important link between cardiovascular risk factors and atherogenesis,” Cellular & Cellular Biology, vol. 41, no. 5, pp. 347–359, 1995. View at Google Scholar · View at Scopus
  22. M. Kanbay, M. I. Yilmaz, M. Apetrii et al., “Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients,” American Journal of Nephrology, vol. 36, no. 3, pp. 228–237, 2012. View at Google Scholar
  23. K. Dewitte, A. Dhondt, M. Giri et al., “Differences in serum ionized and total magnesium values during chronic renal failure between nondiabetic and diabetic patients: a cross-sectional study,” Diabetes Care, vol. 27, no. 10, pp. 2503–2505, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. S. G. Massry, J. W. Coburn, and C. R. Kleeman, “Evidence for suppression of parathyroid gland activity by hypermagnesemia,” Journal of Clinical Investigation, vol. 49, no. 9, pp. 1619–1629, 1970. View at Google Scholar · View at Scopus
  25. I. N. Cholst, S. F. Steinberg, P. J. Tropper, H. E. Fox, G. V. Segre, and J. P. Bilezikian, “The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects,” The New England Journal of Medicine, vol. 310, no. 19, pp. 1221–1225, 1984. View at Google Scholar · View at Scopus
  26. M. Wei, K. Esbaei, J. M. Bargman, and D. G. Oreopoulos, “Inverse correlation between serum magnesium and parathyroid hormone in peritoneal dialysis patients: a contributing factor to adynamic bone disease?” International Urology and Nephrology, vol. 38, no. 2, pp. 317–322, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. J. F. Navarro, C. Mora, A. Jiménez, A. Torres, M. Macía, and J. García, “Relationship between serum magnesium and parathyroid hormone levels in hemodialysis patients,” American Journal of Kidney Diseases, vol. 34, no. 1, pp. 43–48, 1999. View at Google Scholar
  28. M. S. Cho, K. S. Lee, Y. K. Lee et al., “Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate,” Korean Journal of Internal Medicine, vol. 17, no. 2, pp. 114–121, 2002. View at Google Scholar · View at Scopus
  29. D. E. King, “Inflammation and elevation of C-reactive protein: does magnesium play a key role?” Magnesium Research, vol. 22, no. 2, pp. 57–59, 2009. View at Google Scholar · View at Scopus